Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes

Journal of Leukocyte Biology

Volumn 90, Issue 6, 2011, Pages 1149-1157

  Xie, Ping ^a,c   Poovassery, Jayakumar ^a   Stunz, Laura L ^a   Smith, Sonja M ^a   Schultz, Mark L ^a   Carlin, Lindsey E ^a   Bishop, Gail A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Innate immunity; Lymphocyte activation; Signal transduction

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELLS, CULTURED; LYMPHOCYTE ACTIVATION; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; TOLL-LIKE RECEPTORS;

EID: 82555193817     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0111044     Document Type: Article

References (74)

1. Aderem, A., Ulevitch, R. J. (2000) Toll-like receptors in the induction of the innate immune response. Nature 406, 782-787.
2. Kirschning, C. J., Wesche, H., Merrill, A. T., Rothe, M. (1998) Human TLR2 confers responsiveness to bacterial LPS. J. Exp. Med. 188, 2091-2097.
3. Arch, R. H., Gedrich, R. W., Thompson, C. B. (1998) TRAFs-a family of adapter proteins that regulates life and death. Genes Dev. 12, 2821-2830.
4. Häcker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L-C., Wang, G. G., Kamps, M. P., Raz, E., Wagner, H., Häcker, G., Mann, M., Karin, M. (2006) Specificity in TLR signaling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207.
5. Oganesyan, G., Saha, S. K., Guo, B., He, J. Q., Shahangian, A., Zarnegar, B., Perry, A., Cheng, G. (2006) Critical role of TRAF3 in the TLR-dependent and independent antiviral response. Nature 439, 208-211.
6. Pérez de Diego, R., Sancho-Shimizu, V., Lorenzo, L., Puel, A., Plancoulaine, S., Picard, C., Herman, M., Cardon, A., Durandy, A., Bustamante, J., Vallabhapurapu, S., Bravo, J., Warnatz, K., Chaix, Y., Cascarrigny, F., Lebon, P., Rozenberg, F., Karin, M., Tardieu, M., Al-Muhsen, S., Jouanguy, E., Zhang, S-Y., Abel, L., Casanova, J-L. (2010) Human TRAF3 adaptor molecule deficiency leads to impaired TLR3 response and susceptibility to Herpes simplex encephalitis. Immunity 33, 400-411.
7. Akira, S. (2003) TLR signaling. J. Biol. Chem. 278, 38105-38108.
8. Takeda, K., Akira, S. (2005) TLRs in innate immunity. Int. Immunol. 17, 1-14.
9. Kawai, T., Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on TLRs. Nat. Immunol. 11, 373-384.
10. Peng, S. L. (2005) Signaling to B cells by TLRs. Curr. Opin. Immunol. 17, 230-236.
11. Sabroe, I., Read, R. C., Whyte, M. K. B., Dockrell, D. H., Vogel, S. N., Dower, S. K. (2003) TLRs in health and disease: complex questions remain. J. Immunol. 171, 1630-1635.
12. Huang, Q., Pope, R. M. (2010) TLR signaling: a potential link among RA, SLE, and atherosclerosis. J. Leukoc. Biol. 88, 253-262.
13. Kelly-Scumpia, K. M., Scumpia, P. O., Weinstein, J. S., Delano, M. J., Cuenca, A. G., Nacionales, D. C., Wynn, J. L., Lee, P. Y., Kumagai, Y., Efron, P. A., Akira, S., Wasserfall, C., Atkinson, M. A., Moldawer, L. L. (2011) B cells enhance early innate immune responses during bacterial sepsis. J. Exp. Med. 208, 1673-1682.
14. Bishop, G. A. (2004) The multifaceted roles of TRAFs in the regulation of B cell function. Nat. Rev. Immunol. 4, 775-786.
15. Rothe, M., Sarma, V., Dixit, V. M., Goeddel, D. V. (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424-1427.
16. Devergne, O., Hatzivassiliou, E., Izumi, K. M., Kaye, K. M., Kleijnen, M. F., Kieff, E., Mosialos, G. (1996) Association of TRAF1, TRAF2, and TRAF3 with an EBV LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16, 7098-7108.
17. Ishida, T. Mizushima, S., Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., Yamamoto, T., Inoue, J. (1996) Identification of TRAF6, a novel TRAF protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745-28748.
18. Ishida, T. K., Tojo, T., Aoki, T., Kobayashi, N., Ohishi, T., Watanabe, T., Yamamoto, T., Inoue, J-I. (1996) TRAF5, a novel TNF-R-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93, 9437-9442.
19. Hauer, J., Püschner, S., Ramakrishnan, P., Simon, U., Bongers, M., Federle, C., Engelmann, H. (2005) TRAF3 serves as an inhibitor of TRAF2/ 5-mediated activation of the noncanonical NF-ΚB pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. USA 102, 2874-2879.
20. Hostager, B. S., Bishop, G. A. (1999) Cutting edge: contrasting roles of TRAF2 and TRAF3 in CD40-mediated B lymphocyte activation. J. Immunol. 162, 6307-6311.
21. Haxhinasto, S. A., Hostager, B. S., Bishop, G. A. (2002) Cutting edge: molecular mechanisms of synergy between CD40 and the BCR: role for TRAF2 in receptor interaction. J. Immunol. 169, 1145-1149.
22. Xu, L-G., Shu, H-B. (2002) TRAF3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-ΚB activation and IL-10 production. J. Immunol. 169, 6883-6889.
23. Xie, P., Stunz, L. L., Larison, K. D., Yang, B., Bishop, G. A. (2007) TRAF3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27, 253-267.
24. Xie, P., Hostager, B. S., Bishop, G. A. (2004) Requirement for TRAF3 in signaling by LMP1, but not CD40, in B lymphocytes. J. Exp. Med. 199, 661-671.
25. Sinha, S. K., Zachariah, S., Quiñones, H. I., Shindo, M., Chaudhary, P. M. (2002) Role of TRAF3 and 6 in the activation of the NF-κB and JNK pathways by X-linked ectodermal dysplasia receptor. J. Biol. Chem. 277, 44953-44961.
26. Peters, A. L., Plenge, R., Graham, R., Altshuler, D., Moser, K., Gaffney, P. M., Bishop, G. A. (2008) A novel polymorphism of the human CD40 receptor with enhanced function. Blood 112, 1863-1871.
27. Peters, A. L., Bishop, G. A. (2010) Differential TRAF3 utilization by a variant human CD40 receptor with enhanced signaling. J. Immunol. 185, 6555-6562.
28. Force, W. R., Cheung, T. C., Ware, C. F. (1997) Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor. J. Biol. Chem. 272, 30835-30840.
29. Gardam, S., Sierro, S., Basten, A., Mackay, F., Brink, R. (2008) TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28, 391-401.
30. Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T., Yang, X., Yeh, W-C., Mak, T. W., Korneluk, R. G., Cheng, G. (2008) Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378.
31. Xie, P., Kraus, Z. J., Stunz, L. L., Liu, Y., Bishop, G. A. (2011) TRAF3 is required for T cell-mediated immunity and TCR/CD28 signaling. J. Immunol. 186, 143-155.
32. Rickert, R. C., Roes, J., Rajewsky, K. (1997) B lymphocyte-specific, Cremediated mutagenesis in mice. Nucleic Acids Res. 25, 1317-1318.
33. Birnberg, T., Bar-On, L., Sapoznikov, A., Caton, M. L., Cervantes-Barragán, L., Makia, D., Krauthgamer, R., Brenner, O., Ludewig, B., Brockschnieder, D., Riethmacher, D., Rezis, B., Jung, S. (2008) Lack of conventional DC is compatible with normal developent and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 29, 986-997.
34. Roark, J. H., Park, S., Jayawardena, J., Kavita, U., Shannon, M., Bendelac, A. (1998) CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160, 3121-3127.
35. Stunz, L. L., Lenert, P., Peckham, D., Yi, A-K., Haxhinasto, S. A., Chang, M., Krieg, A. M., Ashman, R. F. (2002) Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol. 32, 1212-1222.
36. Baccam, M., Bishop, G. A. (1999) Membrane-bound CD154, but not anti-CD40 mAbs, induces NF-κB independent B cell IL-6 production. Eur. J. Immunol. 29, 3855-3866.
37. Hostager, B. S., Bishop, G. A. (2002) Role of TRAF2 in the activation of IgM secretion by CD40 and CD120b. J. Immunol. 168, 3318-3322.
38. Xie, P., Hostager, B. S., Munroe, M. E., Moore, C. R., Bishop, G. A. (2006) Cooperation between TRAFs 1 and 2 in CD40 signaling. J. Immunol. 176, 5388-5400.
39. Xu, Y., Cheng, G., Baltimore, D. (1996) Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5, 407-415.
40. Andreakos, E., Sacre, S. M., Smith, C. I., Lundberg, A., Kiriakidis, S., Stonehouse, T., Monaco, C., Feldmann, M., Foxwell, B. M. (2004) Distinct pathways of LPS-induced NF-κB activation and cytokine production in human myeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103, 2229-2237.
41. Finkelman, F. D., &/x&&namegr type=editor&&name&&sname&Holmes&/sname&&x&, &/x&&fname&J.&/fname&&/name&&x&, &/x&&name&&sname&Katona&/sname&&x&, &/x&&fname&I. M&/fname&&/name&&x&., &/x&&name&&sname&Urban&/sname&&x&, &/x&&fname&J. F.&/fname&&/name&&x&, &/x&&name&&sname&Beckmann&/sname&&x&, &/x&&fname&M. P.&/fname&&/name&&x&, &/x&&name&&sname&Park&/sname&&x&, &/x&&fname&L. S&/fname&&/name&&x&., &/x&&name&&sname&Schooley&/sname&&x&, &/x&&fname&K. A&/fname&&/name&&x&., Coffman, R. L., Mosmann, T. R., Paul, W. E. (1990) Lymphokine control of in vivo Ig isotype selection. Annu. Rev. Immunol. 8, 303-333.
42. Bishop, G. A., Haxhinasto, S. A., Stunz, L. L., Hostager, B. S. (2003) Antigen-specific B lymphocyte activation. Crit. Rev. Immunol. 23, 149-197.
43. Borst, J., Hendricks, J., Xiao, Y. (2005) CD27 and CD70 in T cell and B cell activation. Curr. Opin. Immunol. 17, 275-281.
44. Turelli, P., Trono, D. (2005) Editing at the crossroad of innate and adaptive immunity. Science 307, 1061-1065.
45. O'Neill, L. A. J. (2006) How TLRs signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3-9.
46. Chaudhuri, J., Alt, F. W. (2004) Class-switch recombination: interplay of transcription, DNA deamination, and DNA repair. Nat. Rev. Immunol. 4, 541-552.
47. Lopes-Carvalho, T., Foote, J., Kearney, J. F. (2005) Marginal zone B cells in lymphocyte activation and regulation. Curr. Opin. Immunol. 17, 244-250.
48. Brummel, R., Lenert, P. (2005) Activation of MZ B cells from Lupus mice with type A(D) CpG-oligodeoxynucleotides. J. Immunol. 174, 2429-2434.
49. Barr, T. A., Brown, S., Ryan, G., Zhao, J., Gray, D. (2007) TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37, 3040-3053.
50. Tseng, P-H., Matsuzawa, A., Zhang, W., Mino, T., Vignali, D. A. A., Karin, M. (2010) Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11, 70-75.
51. Mann, J., Oakley, F., Johnson, P. W., Mann, D. A. (2002) CD40 induces IL-6 gene transcription in DC: regulation by TRAF2, AP-1, NF-κB and CBF1. J. Biol. Chem. 277, 17125-17138.
52. Jalukar, S. V., Hostager, B. S., Bishop, G. A. (2000) Characterization of the roles of TRAF6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 164, 623-630.
53. Hostager, B. S., Haxhinasto, S. A., Rowland, S. R., Bishop, G. A. (2003) TRAF2-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J. Biol. Chem. 278, 45382-45390.
54. Mukundan, L., Bishop, G. A., Head, K. Z., Zhang, L., Wahl, L. M., Suttles, J. (2005) TRAF6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. J. Immunol. 174, 1081-1090.
55. Brown, K. D., Hostager, B. S., Bishop, G. A. (2002) Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 277, 19433-19438.
56. Moore, C. R., Bishop, G. A. (2005) Differential regulation of CD40-mediated TRAF degradation in B lymphocytes. J. Immunol. 175, 3780-3789.
57. Moore, C. (2006) Degradation of TRAFs: characterization and consequences. Ph.D. dissertation, The University of Iowa.
58. Davies, C. C., Mak, T. W., Young, L. S., Eliopoulos, A. G. (2005) TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells. Mol. Cell. Biol. 25, 9806-9819.
59. Munroe, M. E., Bishop, G. A. (2004) Role of TRAF2 in distinct and overlapping CD40 and TNFR2/CD120b-mediated B lymphocyte activation. J. Biol. Chem. 279, 53222-53231.
60. Andrade, R. M., Wessendarp, M., Portillo, J-A. C., Yang, J-Q., Gomez, F. J., Durbin, J. E., Bishop, G. A., Subauste, C. S. (2005) TRAF6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-α. J. Immunol. 175, 6014-6021.
61. Grech, A. P., Gardam, S., Chan, T., Quinn, R., Gonzales, R., Basten, A., Brink, R. (2005) TNFR2 signaling is negatively regulated by a novel, carboxyl-terminal TRAF2 binding site. J. Biol. Chem. 280, 31572-31581.
62. Sen, R. (2006) Control of B lymphocyte apoptosis by the transcription factor NF-κB. Immunity 25, 871-883.
63. Liao, G., Zhang, M., Harhaj, E. W., Sun, S-C. (2004) Regulation of NIK by TRAF3-induced degradation. J. Biol. Chem. 279, 26243-26250.
64. Ramakrishnan, P., Wang, W., Wallach, D. (2004) Receptor-specific signaling for both the alternative and canonical NF-κB activation pathways by NIK. Immunity 21, 477-489.
65. Zarnegar, B., Yamazaki, S., He, J. Q., Cheng, G. (2008) Control of canonical NF-κB activation through the NIK-IKK pathway. Proc. Natl. Acad. Sci. USA 105, 3503-3508.
66. Rowland, S. L., Tremblay, M. L., Ellison, J. M., Stunz, L. L., Bishop, G. A., Hostager, B. S. (2007) A novel mechanism for TRAF6-dependent CD40 signaling. J. Immunol. 179, 4645-4653.
67. Ahonen, C., Manning, E. M., Erickson, L. D., O'Connor, B. P., Lind, E. F., Pullen, S. S., Kehry, M. R., Noelle, R. J. (2002) The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat. Immunol. 3, 451-456.
68. Burdin, N., Van Kooten, C., Galibert, L., Abrams, J. S., Wijdenes, J., Banchereau, J., Rousset, F. (1995) Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 154, 2533-2544.
69. Oka, Y., Rolink, A. G., Suematsu, S., Kishimoto, T., Melchers, F. (1995) An IL-6 transgene expressed in B lymphocyte lineage cells overcomes the T cell-dependent establishment of normal levels of switched Ig isotypes. Eur. J. Immunol. 25, 1332-1337.
70. Pullen, S. S., Miller, H. G., Everdeen, D. S., Dang, T. T. A., Crute, J. J., Kehry, M. R. (1998) CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37, 11836-11845.
71. He, L., Grammer, A. C., Wu, X., Lipsky, P. E. (2004) TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-κB activation. J. Biol. Chem. 279, 55855-55865.
72. Brown, K. D., Hostager, B. S., Bishop, G. A. (2001) Differential signaling and TRAF degradation by CD40 and the EBV oncoprotein LMP1. J. Exp. Med. 193, 943-954.
73. Gantner, F., Hermann, P., Nakashima, K., Matsukawa, S., Sakai, K., Bacon, K. B. (2003) CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur. J. Immunol. 33, 1576-1585.
74. Vanden Bush, T. J., Bishop, G. A. (2008) TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation. Eur. J. Immunol. 38, 400-409.